These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 36256511

  • 1. The many faces of globular glial tauopathy: A clinical and imaging study.
    Buciuc M, Koga S, Pham NTT, Duffy JR, Knopman DS, Ali F, Boeve BF, Graff-Radford J, Botha H, Lowe VJ, Nguyen A, Reichard RR, Dickson DW, Petersen RC, Whitwell JL, Josephs KA.
    Eur J Neurol; 2023 Feb; 30(2):321-333. PubMed ID: 36256511
    [Abstract] [Full Text] [Related]

  • 2. FDG-PET in pathologically confirmed spontaneous 4R-tauopathy variants.
    Zalewski N, Botha H, Whitwell JL, Lowe V, Dickson DW, Josephs KA.
    J Neurol; 2014 Apr; 261(4):710-6. PubMed ID: 24492888
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Progressive supranuclear palsy and primary lateral sclerosis secondary to globular glial tauopathy: a case report and a practical theoretical framework for the clinical prediction of this rare pathological entity.
    Liu AJ, Chang JE, Naasan G, Boxer AL, Miller BL, Spina S.
    Neurocase; 2020 Apr; 26(2):91-97. PubMed ID: 32090696
    [Abstract] [Full Text] [Related]

  • 5. Clinical, radiologic, and pathologic features of the globular glial tauopathy subtype of frontotemporal lobar degeneration in right temporal variant frontotemporal dementia with salient features of Geschwind syndrome.
    Josephy-Hernandez S, Brickhouse M, Champion S, Kim DD, Touroutoglou A, Frosch M, Dickerson BC.
    Neurocase; 2022 Aug; 28(4):375-381. PubMed ID: 36251576
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A Case of Pathologically Confirmed Corticobasal Degeneration Initially Presenting as Progressive Supranuclear Palsy Syndrome.
    Chung EJ, Cho HJ, Jang W, Hur DY, Kim YS, Lee KH, Kim SJ.
    J Korean Med Sci; 2022 Jun 06; 37(22):e183. PubMed ID: 35668689
    [Abstract] [Full Text] [Related]

  • 9. The evolution of primary progressive apraxia of speech.
    Josephs KA, Duffy JR, Strand EA, Machulda MM, Senjem ML, Gunter JL, Schwarz CG, Reid RI, Spychalla AJ, Lowe VJ, Jack CR, Whitwell JL.
    Brain; 2014 Oct 06; 137(Pt 10):2783-95. PubMed ID: 25113789
    [Abstract] [Full Text] [Related]

  • 10. Corpus callosum hypersignals and focal atrophy: Neuroimaging findings in globular glial tauopathy type I.
    Keller J, Kavkova A, Matej R, Cséfalvay Z, Rusina R.
    Eur J Neurol; 2022 Jan 06; 29(1):324-328. PubMed ID: 34469612
    [Abstract] [Full Text] [Related]

  • 11. Atypical globular glial tauopathy with a combination of types I and II pathology.
    Kon T, Mori F, Arai A, Miki Y, Tanji K, Kurotaki H, Tomiyama M, Wakabayashi K.
    Neuropathology; 2019 Apr 06; 39(2):127-134. PubMed ID: 30723950
    [Abstract] [Full Text] [Related]

  • 12. Globular glial tauopathies (GGT) presenting with motor neuron disease or frontotemporal dementia: an emerging group of 4-repeat tauopathies.
    Ahmed Z, Doherty KM, Silveira-Moriyama L, Bandopadhyay R, Lashley T, Mamais A, Hondhamuni G, Wray S, Newcombe J, O'Sullivan SS, Wroe S, de Silva R, Holton JL, Lees AJ, Revesz T.
    Acta Neuropathol; 2011 Oct 06; 122(4):415-28. PubMed ID: 21773886
    [Abstract] [Full Text] [Related]

  • 13. Tau exhibits unique seeding properties in globular glial tauopathy.
    Chung DC, Carlomagno Y, Cook CN, Jansen-West K, Daughrity L, Lewis-Tuffin LJ, Castanedes-Casey M, DeTure M, Dickson DW, Petrucelli L.
    Acta Neuropathol Commun; 2019 Mar 07; 7(1):36. PubMed ID: 30845985
    [Abstract] [Full Text] [Related]

  • 14. Globular glial tauopathy Type I presenting with behavioral variant frontotemporal dementia.
    Hirano M, Iritani S, Fujishiro H, Torii Y, Kawashima K, Sekiguchi H, Habuchi C, Yamada K, Ikeda T, Hasegawa M, Ikeuchi T, Yoshida M, Ozaki N.
    Neuropathology; 2020 Oct 07; 40(5):515-525. PubMed ID: 33463808
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia.
    Hassan A, Parisi JE, Josephs KA.
    Neurocase; 2012 Oct 07; 18(6):478-88. PubMed ID: 22181323
    [Abstract] [Full Text] [Related]

  • 17. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
    Riku Y, Iwasaki Y, Ishigaki S, Akagi A, Hasegawa M, Nishioka K, Li Y, Riku M, Ikeuchi T, Fujioka Y, Miyahara H, Sone J, Hattori N, Yoshida M, Katsuno M, Sobue G.
    Brain; 2022 Aug 27; 145(8):2769-2784. PubMed ID: 35274674
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy.
    Boxer AL, Geschwind MD, Belfor N, Gorno-Tempini ML, Schauer GF, Miller BL, Weiner MW, Rosen HJ.
    Arch Neurol; 2006 Jan 27; 63(1):81-6. PubMed ID: 16401739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.